Actinium to present ATNM-400 cancer data at EANM 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 1.40 +0.02 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.38 | 52 Week High | $3.50 | |||
| Open | $1.33 | 52 Week Low | $0.86 | |||
| Day High | $1.41 | P/E | N/A | |||
| Day Low | $1.33 | EPS | $-7.61 | |||
| Volume | 32,843 | |||||
